TECX Q3 2018 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$634M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$130,000

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-5.86

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$143M

Total Liabilities

$6M

Stockholders' Equity

$137M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$130,000	-$13,000	-900.0%
Operating Income	-$12M	-$6M	-92.0%
Net Income	-$12M	-$6M	-80.0%